Immix Biopharma, Inc. (IMMX)
14.07
-0.40
(-2.76%)
USD |
NASDAQ |
Aug 26, 16:00
14.50
+0.43
(+3.06%)
After-Hours: 20:00
Immix Biopharma Market Cap : 1.007B for Aug. 26, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 26, 2026 | 1.007B |
| August 25, 2026 | 1.035B |
| August 24, 2026 | 973.60M |
| August 21, 2026 | 977.18M |
| August 20, 2026 | 941.41M |
| August 19, 2026 | 943.56M |
| August 18, 2026 | 844.84M |
| August 17, 2026 | 811.21M |
| August 14, 2026 | 784.75M |
| August 13, 2026 | 781.17M |
| August 12, 2026 | 813.36M |
| August 11, 2026 | 821.95M |
| August 10, 2026 | 724.66M |
| August 07, 2026 | 695.33M |
| August 06, 2026 | 719.65M |
| August 05, 2026 | 682.45M |
| August 04, 2026 | 494.60M |
| August 03, 2026 | 446.36M |
| July 31, 2026 | 441.06M |
| July 30, 2026 | 453.25M |
| July 29, 2026 | 433.11M |
| July 28, 2026 | 447.42M |
| July 27, 2026 | 460.68M |
| July 24, 2026 | 451.66M |
| July 23, 2026 | 466.51M |
| Date | Value |
|---|---|
| July 22, 2026 | 498.84M |
| July 21, 2026 | 507.33M |
| July 20, 2026 | 466.51M |
| July 17, 2026 | 543.37M |
| July 16, 2026 | 533.30M |
| July 15, 2026 | 558.22M |
| July 14, 2026 | 566.17M |
| July 13, 2026 | 557.69M |
| July 10, 2026 | 588.96M |
| July 09, 2026 | 587.90M |
| July 08, 2026 | 583.13M |
| July 07, 2026 | 637.21M |
| July 06, 2026 | 553.98M |
| July 02, 2026 | 548.15M |
| July 01, 2026 | 521.11M |
| June 30, 2026 | 546.55M |
| June 29, 2026 | 556.10M |
| June 26, 2026 | 529.06M |
| June 25, 2026 | 515.28M |
| June 24, 2026 | 532.24M |
| June 23, 2026 | 525.35M |
| June 22, 2026 | 498.31M |
| June 18, 2026 | 462.27M |
| June 17, 2026 | 484.00M |
| June 16, 2026 | 463.33M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Savara, Inc. | 1.152B |
| SELLAS Life Sciences Group, Inc. | 2.772B |
| Atossa Therapeutics, Inc. | 26.45M |
| Marker Therapeutics, Inc. | 24.18M |
| Krystal Biotech, Inc. | 10.65B |
Market Cap Related Metrics
| PEG Ratio | -1.426 |
| Price to Book Value | 4.397 |
| Price | 14.07 |
| Earnings Yield | -6.26% |
| PEGY Ratio | -1.426 |